SecBot SecBot
PRESS-RELEASE ·Filed Jun 8, 2026

ELAB

PMGC Holdings Inc.
NEUTRAL
Impact 4/10
Horizonmonths Processed4mo ago WireGlobeNewswire
Press release · Contract
Actionable Insight • Neutral

This is a speculative, early-stage licensing deal with no hard financials.

DirectionNeutral
Confidencemedium
Horizonmonths
Final — all horizons settled through T+60d
ELAB ▼ -67.99% at T+60d
NEUTRAL call -67.99% · α vs SPY -71.50% · entry $1.59 → $0.5090
Entry = T+0 close
Jun 8, 2026
via day close
T+1d
-11.32%
call -11.32% · α -11.03%
$1.41
settled 5mo ago
T+5d
-8.18%
call -8.18% · α -10.29%
$1.46
settled 4mo ago
T+20d
-33.33%
call -33.33% · α -34.17%
$1.06
settled 4mo ago
T+60d
-67.99%
call -67.99% · α -71.50%
$0.5090
settled 8w ago

Price Chart

Loading chart...

Executive Summary

PMGC Holdings subsidiary NorthStrive Defense Tech signed a binding term sheet for an exclusive, worldwide, sublicensable license to a U.S. patent covering autonomous buoyancy-assisted drone payload transport across air and water, plus a 12-month sponsored research agreement. The deal is early-stage with no disclosed financial terms, no revenue, and no near-term commercial product — a speculative technology licensing event for a micro-cap company.

Key Facts

  • Binding term sheet for exclusive, worldwide, sublicensable license to U.S. Patent No. 12,291,334 in aerospace and defense field.
  • Sponsored research agreement: 12-month term (June 2026 to June 2027), milestone-based funding, no dollar amounts disclosed.
  • No revenue, no purchase orders, no contract awards — technology is at prototype stage.
  • Cross-filing actuarial verdicts flag amplifiers for press-8k-context + press-offering-context, but no offering or 8-K context is present in this filing.

Financial Impact

No financial terms disclosed — license fee, royalties, or research funding amounts are not stated.

Risk Factors

  • No disclosed financial terms — license fee, royalties, or research costs unknown.
  • Technology is at prototype stage; no guarantee of successful development or commercial adoption.
  • Micro-cap ($7M) with poor historical filing performance — high risk of continued downside drift.
  • Forward-looking statements are aspirational; no binding customer commitments or revenue.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3307996
27 reports for ELAB
Performance horizon
33% Hit rate @ T+1 2 of 6 directional calls Went positive at some point 2 of 6 best @ T+60▲ +66.87%Apr 20, 2026
Filters
Rows
Reports for ELAB — sortable, filterable
TypeNow
Sep 29, 2026
27d ago
Press Release
NEUTRAL ★ 3/10
$3.67 $3.54▼ −3.54%▼ −3.34%$2.61 (−28.88%)
Sep 18, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$4.78 $4.42▼ −7.53%▼ −9.08%$2.61 (−45.40%)
Sep 18, 2026
5w ago
Press Release
NEUTRAL ★ 4/10
$4.78 $4.42▼ −7.53%▼ −9.08%$2.61 (−45.40%)
Aug 19, 2026
9w ago
Press Release
NEUTRAL ★ 3/10
$0.5603 $0.6100▲ +8.87%▲ +9.71%$2.61 (+365.82%)
Aug 14, 2026
10w ago
Press Release
NEUTRAL ★ 3/10
$0.9100 $0.8730▼ −4.07%▼ −3.59%$2.61 (+186.81%)
Jul 29, 2026
12w ago
Press Release
NEUTRAL ★ 3/10
$0.8800 $0.9493▲ +7.88%▲ +6.20%$2.61 (+196.59%)
Jul 9, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$1.12 $1.09▼ −2.68%▼ −1.91%$2.61 (+133.04%)
Jul 1, 2026
16w ago
8-K
BULLISH ★ 5/10
$1.28 $1.18▼ −7.81%▼ −7.68%$2.61 (+103.91%)
Jun 8, 2026
20w ago
Press Release
NEUTRAL ★ 4/10
$1.59 $1.41▼ −11.32%▼ −11.03%$2.61 (+64.15%)
Jun 5, 2026
20w ago
8-K
NEUTRAL ★ 4/10
$1.59 $1.41▼ −11.32%▼ −11.03%$2.61 (+64.15%)
Showing 10 of 27

US Market Status

Market Closed — Opens in 3h 31m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 8, 2026